Akèy › Enfeksyon COVID-19 ak Koronaviris › North Carolina
Etid klinik pou Enfeksyon COVID-19 ak Koronaviris nan North Carolina
5 etid pou Enfeksyon COVID-19 ak Koronaviris ap chèche patisipan nan sit nan North Carolina.
Vil nan North Carolina
Tèks ofisyèl etid la (Anglè)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Durham
- Research Site, Winston-Salem
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05624450A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Duke Vaccine and Trials Unit, Durham
- Duke Vaccine and Trials Unit, Durham
- Duke University - Main Hospital and Clinics, Durham
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07013474Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Duke University Health System, Durham
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 0 a 20 · Tout sèks · Mizajou Aug 21, 2026 · NCT04278404A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
- Duke Vaccine and Trials Unit, Durham
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 a 64 · Tout sèks · Mizajou Aug 7, 2026 · NCT07730450Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- Duke University, Durham
Ap rekriteFaz 3
Tout laj · Tout sèks · Mizajou Jun 23, 2026 · NCT03808922Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.